Fat Loss

Peptides and strategies for fat loss

Fat Loss | News | Peptides

BREAKING: FDA Flags Risks of Unapproved GLP-1 Drugs for Weight Loss
ByLee Maasen September 4, 2026

Read More BREAKING: FDA Flags Risks of Unapproved GLP-1 Drugs for Weight Loss
Fat Loss | Peptides

Mazdutide vs Retatrutide: Dual vs Triple Glucagon Map
ByLee Maasen September 3, 2026

Read More Mazdutide vs Retatrutide: Dual vs Triple Glucagon Map
Fat Loss | Peptides

PT-141 (Bremelanotide): Desire Research + Rx Map
ByLee Maasen September 3, 2026

Read More PT-141 (Bremelanotide): Desire Research + Rx Map
Fat Loss | Peptides

Retatrutide: Triple Agonist Research Map
ByLee Maasen September 3, 2026September 3, 2026

Read More Retatrutide: Triple Agonist Research Map
Fat Loss | Peptides

NAD+: Longevity Education & Research Catalog Literacy
ByLee Maasen September 3, 2026September 3, 2026

Read More NAD+: Longevity Education & Research Catalog Literacy
Fat Loss | Peptides

5-Amino-1MQ: NNMT Metabolic Research Map
ByLee Maasen September 2, 2026

Read More 5-Amino-1MQ: NNMT Metabolic Research Map
Fat Loss | Peptides

SS-31 (Elamipretide): Mitochondrial Peptide Research Map
ByLee Maasen September 2, 2026September 2, 2026

Read More SS-31 (Elamipretide): Mitochondrial Peptide Research Map
Fat Loss | Peptides

AOD-9604: hGH Fragment vs GLP-1 Fat-Loss Map
ByLee Maasen September 2, 2026September 2, 2026

Read More AOD-9604: hGH Fragment vs GLP-1 Fat-Loss Map
Fat Loss | Peptides

Tesamorelin: GHRH Analog, Visceral Fat Literature, GH Map
ByLee Maasen September 1, 2026September 2, 2026

Read More Tesamorelin: GHRH Analog, Visceral Fat Literature, GH Map
Fat Loss | Peptides

MOTS-c: The Mitochondrial Peptide
ByLee Maasen August 28, 2026September 2, 2026

Read More MOTS-c: The Mitochondrial Peptide